Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.
about
Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis.Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.Direct renin inhibition--a promising strategy for renal protection?Angiotensin II receptors are expressed and functional in human esophageal mucosa.Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?Renin inhibition with aliskiren.Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension.Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.Support for involvement of the renin-angiotensin system in dysplastic Barrett's esophagus.
P2860
Q34453476-3E886895-ED98-4361-B757-7BAA2F29BE44Q35326017-AB913E46-7ECF-4C5F-8B4E-2626ED69EBB3Q35826450-C26C633C-6168-4A0E-B806-EE4F17FF9A6CQ37364926-950690B1-83FB-47B9-A165-AD1BE152BF1EQ38113702-D1F1856C-2C13-4D96-914D-5FD12D5640E3Q42460365-C88FC118-362C-47CB-8DB5-578FF9E767C3Q44430217-0D959C2E-BBD7-4FC2-BD68-789B1336F838Q45915296-7F7F6C91-DE71-4FE9-9E12-624C159D75EEQ46727866-65E3748D-D7FC-467E-BEC8-2DB874E06210Q46842382-97A886AF-7E9E-44EC-B363-F68F41567D4FQ48005483-F9C1F3C0-29AF-448B-95D7-7D763BC1A5EFQ51326132-90AB334A-763B-41D6-A557-6E85119A4567
P2860
Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Integrating drug pharmacokinet ...... otensin II blockade in humans.
@en
Integrating drug pharmacokinet ...... otensin II blockade in humans.
@nl
type
label
Integrating drug pharmacokinet ...... otensin II blockade in humans.
@en
Integrating drug pharmacokinet ...... otensin II blockade in humans.
@nl
prefLabel
Integrating drug pharmacokinet ...... otensin II blockade in humans.
@en
Integrating drug pharmacokinet ...... otensin II blockade in humans.
@nl
P2093
P1433
P1476
Integrating drug pharmacokinet ...... otensin II blockade in humans.
@en
P2093
Alvine Bissery
Joël Ménard
Maxime Lamarre-Cliche
Michel Azizi
P304
P356
10.1161/01.HYP.0000125698.00128.64
P407
P577
2004-03-15T00:00:00Z